Carla Loreto

Prof. Dr. Carla Loreto

Department of Biomedical and Biotechnological Sciences Section of Anatomy and Histology, University of Catania, via Santa Sofia no. 87, Catania (CT), Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Orthopedics
Verified
Journal Article
Closed access
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
PCPaola Castrogiovanni
Paola Castrogiovanni
Marta Anna SzychlinskaMarta Anna Szychlinska
Marta Anna Szychlinska
RLRosalia Leonardi
Rosalia Leonardi
FTFrancesca Maria Trovato
Francesca Maria Trovato
Sergio CastorinaSergio Castorina
Sergio Castorina
In this paper review we describe benefits and disadvantages of the established methods of cartilage regeneration that seem to have a better long-term effectiveness. We illustrated the anatomical aspect of the knee joint cartilage, the current state of cartilage tissue engineering, through mesenchymal stem cells and biomaterials, and in conclusion we provide a short overview on the rehabilitation after articular cartilage repair procedures. Adult articular cartilage has low capacity to repair itself, and thus even minor injuries may lead to progressive damage and osteoarthritic joint degeneration, resulting in significant pain and disability. Numerous efforts have been made to develop tissue-engineered grafts or patches to repair focal chondral and osteochondral defects, and to date several researchers aim to implement clinical application of cell-based therapies for cartilage repair. A literature review was conducted on PubMed, Scopus and Google Scholar using appropriate keywords, examining the current literature on the well-known tissue engineering methods for the treatment of knee osteoarthritis.

1 December 2013 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
FTFrancesca Maria Trovato
Francesca Maria Trovato
KPKarin Pichler
Karin Pichler
AWAnnelie Martina Weinberg
Annelie Martina Weinberg
Carla LoretoCarla Loreto
Carla Loreto
PCPaola Castrogiovanni
Paola Castrogiovanni

9 July 2014 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
PCPaola Castrogiovanni
Paola Castrogiovanni
FTFrancesca Maria Trovato
Francesca Maria Trovato
RIRosa Imbesi
Rosa Imbesi
SGSalvatore Giunta
Salvatore Giunta
Ali MobasheriAli Mobasheri
Ali Mobasheri

Verified
Journal Article
Open access
PDF file
PCPaola Castrogiovanni
Paola Castrogiovanni
FTFrancesca Maria Trovato
Francesca Maria Trovato
Carla LoretoCarla Loreto
Carla Loreto
HNHouda Nsir
Houda Nsir
Marta Anna SzychlinskaMarta Anna Szychlinska
Marta Anna Szychlinska
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
Nutraceuticals are dietary compounds which have a role in the balance of anabolic and catabolic signals in joints. Their regulatory function on homeostasis of cartilage metabolism nutraceuticals is increasingly considered for the management and, above all, the prevention of osteoarthritis (OA). OA is a degenerative disease characterized by cartilage and synovium inflammation that can cause joint stiffness, swelling, pain, and loss of mobility. It is a multifactorial disease and, due to the great percentage of people suffering from it and the general increase in life expectancy, OA is considered as one of the most significant causes of disability in the world. OA impairs the structural integrity of articular cartilage that greatly depends on a balance between the anabolic and catabolic processes which occur in chondrocytes and synovial fluid of the joints, therefore the integration with nutraceutical compounds in diet increases the treatment options for patients with established OA beyond traditional rehabilitation, medications, and surgical strategies. In our review, with respect to the current literature, we highlight some of many existing nutraceutical compounds that could be used as integrators in a daily diet thanks to their easy availability, such as in olive oil, fish oil, and botanical extracts used as non-pharmacologic treatment.

20 July 2010 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
Carla LoretoCarla Loreto
Carla Loreto
MCMaria Luisa Carnazza
Maria Luisa Carnazza
GMGiuseppa Martinez
Giuseppa Martinez

13 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Carla LoretoCarla Loreto
Carla Loreto
GRGiampiero La Rocca
Giampiero La Rocca
RARita Anzalone
Rita Anzalone
Rosario CaltabianoRosario Caltabiano
Rosario Caltabiano
GVGiuseppe Vespasiani
Giuseppe Vespasiani
SSSalvatore Sansalone
Salvatore Sansalone
Peyronie’s disease (PD) is characterized with formation of fibrous plaques which result in penile deformity, pain, and erectile dysfunction. The aim of this study was to investigate the activation of the intrinsic apoptotic pathway in plaques from PD patients. Tunica albuginea from either PD or control patients was assessed for the expression of bax, bcl-2 and caspases 9 and 3 using immunohistochemistry and by measurement of apoptotic cells using TUNEL assay. Bax overexpression was observed in metaplastic bone tissue, in fibroblasts, and in myofibroblast of plaques from PD patients. Little or no bcl-2 immunostaining was detected in samples from either patients or controls. Caspase 3 immunostaining was very strong in fibrous tissue, in metaplasic bone osteocytes, and in primary ossification center osteoblasts. Moderate caspase 9 immunostaining was seen in fibrous cells plaques and in osteocytes and osteoblasts of primary ossification centers from PD patients. Control samples were negative for caspase 9 immunostaining. In PD patients the TUNEL immunoassay showed intense immunostaining of fibroblasts and myofibroblasts, the absence of apoptotic cells in metaplasic bone tissue and on the border between fibrous and metaplastic bone tissue. Apoptosis occurs in stabilized PD plaques and is partly induced by the intrinsic pathway.